Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes (Q30891442)

27 June 2017

title

Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes (English)

1 reference

27 June 2017

1 reference

Michael J Sampson

1

1 reference

27 June 2017

Isabel R Davies

2

1 reference

27 June 2017

Simon Braschi

3

1 reference

27 June 2017

Kamal Ivory

4

1 reference

27 June 2017

David A Hughes

5

1 reference

27 June 2017

publication date

1 March 2003

1 reference

27 June 2017

1 reference

27 June 2017

volume

167

1 reference

27 June 2017

issue

1

1 reference

27 June 2017

page(s)

129-134

1 reference

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

7 January 2021

CD36 and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Levels of expression of Fcgamma receptor IIA (CD32) are decreased on peripheral blood monocytes in patients with severe atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Enumeration of human lymphocyte subsets by monoclonal antibodies and flow cytometry: a comparative study using whole blood or mononuclear cells separated by density gradient centrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Procedural guidelines for performing immunophenotyping by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry (FACS) analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Significance and immunoassay of 9- and 13-hydroxyoctadecadienoic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900421-5

10.1016/S0021-9150(02)00421-5

7 January 2021

Identifiers

DOI

1 reference

27 June 2017

1 reference